Antibodies to MOG in adults with
inflammatory demyelinating disease of
the CNS

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS

Bibliographic Details
Main Authors:	Waters, P, Woodhall, M, Vincent, A
Format:	Journal article
Published:	American Academy of Neurology 2015

Similar Items

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
by: Bing-Yan Ren, et al.
Published: (2021-02-01)

Recurrent optic neuritis associated with MOG antibody seropositivity
by: Chang, T, et al.
Published: (2017)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
by: Yeo, T, et al.
Published: (2020)

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies
by: Tianrong Yeo, et al.
Published: (2020-03-01)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
by: Elsone, L, et al.
Published: (2014)

The Role of Peripheral CNS‐Directed Antibodies in Promoting Inflammatory CNS Demyelination
by: Silke Kinzel, et al.
Published: (2017-06-01)

Adrenoleukodystrophy-like presentation of MOG-antibody-associated demyelination
by: Lakshminarayanapuram Gopal Viswanathan, et al.
Published: (2024-01-01)

Peripheral nervous system involvement in MOG antibody-associated demyelination
by: Ramanathan, S, et al.
Published: (2019)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2016)

International multicenter examination of MOG antibody assays
by: Reindl, M, et al.
Published: (2020)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
by: Kitley, J, et al.
Published: (2011)

Disease course and disability outcomes in MOG-antibody disease in the UK
by: Jurynczyk, M, et al.
Published: (2017)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
by: Park, K, et al.
Published: (2012)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.
by: Morris, K, et al.
Published: (2015)

Atypical inflammatory demyelinating syndromes of the CNS
by: Hardy, T, et al.
Published: (2016)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
by: Jurynczyk, M, et al.
Published: (2017)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
by: Carsten Tue Berg, et al.
Published: (2017-06-01)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
by: Che Serguera, et al.
Published: (2019-11-01)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
by: Jurynczyk, M, et al.
Published: (2017)

Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.
by: Hyun, JW, et al.
Published: (2017)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
by: Yang, H, et al.
Published: (2012)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
by: Waters, P, et al.
Published: (2015)

An international multicentre validation experiment for MOG antibodies
by: Reindl, M, et al.
Published: (2018)

Aquaporin-4 antibodies in Korean patients with idiopathic inflammatory demyelinating diseases of the central nervous system
by: Kim, J, et al.
Published: (2013)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
by: Juryńczyk, M, et al.
Published: (2016)

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
by: Sonja Hochmeister, et al.
Published: (2020-02-01)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
by: Maciej Jurynczyk, et al.
Published: (2017-12-01)

Tumefactive demyelination—A rare presentation of Anti-MOG Syndrome
by: Sesh Sivadasan, et al.
Published: (2022-01-01)

Glycine receptor antibody — a marker for NMO/ NON-MS demyelination?
by: Hamid, S, et al.
Published: (2015)

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
by: Waters, P, et al.
Published: (2019)

Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease
by: Ashutosh Mangalam, et al.
Published: (2017-08-01)

Sentinel inflammatory demyelinating lesions preceding primary CNS lymphoma
by: Danielle Mesquita TORRES, et al.
Published: (2021-06-01)

Epilepsy in patients with MOG antibody disease
by: Varvara E. Avdeeva, et al.
Published: (2021-10-01)

MOG-IgG1 antibodies in children
by: Waters, P, et al.
Published: (2018)

Measles–rubella vaccine–associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child
by: Madhumati Otiv, et al.
Published: (2022-08-01)

Back on the scent: the olfactory system in CNS demyelinating diseases
by: Joseph, A, et al.
Published: (2016)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
by: Pace, S, et al.
Published: (2021)

Anterior optic pathway pathology in CNS demyelinating diseases
by: Pisa, M, et al.
Published: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
by: Franziska Di Pauli, et al.
Published: (2018-11-01)